Teva Pharmaceutical Industries Ltd. (TEVA)
35.32
+0.80
(+2.32%)
USD |
NYSE |
May 29, 16:00
35.16
-0.16
(-0.45%)
After-Hours: 20:00
Teva Pharmaceutical Industries Shareholders Equity (Quarterly) : 8.228B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viatris, Inc. | 14.66B |
| Johnson & Johnson | 81.19B |
| Novartis AG | 38.51B |
| Pfizer Inc. | 90.10B |
| AstraZeneca PLC | 47.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.04B |
| Total Liabilities (Quarterly) | 31.81B |
| Debt to Equity Ratio | 2.055 |
| Current Ratio | 1.013 |
| Net Debt Paydown Yield | 0.72% |